Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
78.78
+1.38 (1.78%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Haemonetics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
| 3,580 | 2,445 | 3,047 | 4,335 | 4,175 | 3,264 | |
Market Cap Growth | -0.04% | -19.74% | -29.71% | 3.84% | 27.89% | -42.73% |
Enterprise Value | 4,609 | 3,425 | 3,965 | 4,964 | 4,656 | 3,778 |
Last Close Price | 78.78 | 54.04 | 63.19 | 85.35 | 82.75 | 63.85 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
PE Ratio | 38.43 | 26.36 | 19.09 | 37.27 | 36.94 | 76.01 |
Forward PE | 15.10 | 10.46 | 13.21 | 20.49 | 25.45 | 23.82 |
PEG Ratio | 1.39 | 0.96 | 1.00 | 1.39 | 2.42 | 1.36 |
PS Ratio | 2.68 | 1.83 | 2.24 | 3.31 | 3.57 | 3.29 |
PB Ratio | 4.48 | 3.07 | 3.71 | 4.52 | 5.10 | 4.36 |
P/TBV Ratio | - | - | - | - | 55.99 | - |
P/FCF Ratio | 13.75 | 9.39 | 21.39 | 30.18 | 51.08 | 43.09 |
P/OCF Ratio | 12.21 | 8.34 | 16.77 | 23.85 | 15.29 | 18.95 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
EV/Sales Ratio | 3.45 | 2.57 | 2.91 | 3.79 | 3.98 | 3.80 |
EV/EBITDA Ratio | 17.17 | 12.76 | 11.75 | 18.94 | 18.67 | 21.17 |
EV/EBIT Ratio | 29.40 | 21.85 | 17.87 | 30.10 | 29.84 | 46.79 |
EV/FCF Ratio | 17.70 | 13.15 | 27.83 | 34.56 | 56.97 | 49.88 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Debt / Equity Ratio | 1.54 | 1.54 | 1.49 | 0.84 | 0.94 | 1.03 |
Debt / EBITDA Ratio | 4.56 | 4.56 | 3.63 | 3.08 | 3.07 | 4.33 |
Debt / FCF Ratio | 4.70 | 4.70 | 8.60 | 5.62 | 9.37 | 10.21 |
Net Debt / Equity Ratio | 1.23 | 1.23 | 1.12 | 0.66 | 0.59 | 0.69 |
Net Debt / EBITDA Ratio | 3.65 | 3.65 | 2.72 | 2.40 | 1.93 | 2.88 |
Net Debt / FCF Ratio | 3.76 | 3.76 | 6.45 | 4.38 | 5.89 | 6.79 |
Asset Turnover | 0.55 | 0.55 | 0.59 | 0.63 | 0.62 | 0.54 |
Inventory Turnover | 1.74 | 1.63 | 1.79 | 2.14 | 2.00 | 1.58 |
Quick Ratio | 1.64 | 1.64 | 0.88 | 1.28 | 1.84 | 0.95 |
Current Ratio | 2.95 | 2.95 | 1.62 | 2.56 | 3.06 | 1.71 |
Return on Equity (ROE) | 11.40% | 12.03% | 18.83% | 13.22% | 14.72% | 5.86% |
Return on Assets (ROA) | 4.88% | 4.92% | 7.55% | 6.18% | 6.71% | 2.99% |
Return on Invested Capital (ROIC) | 6.71% | 6.78% | 10.54% | 8.84% | 9.94% | 4.38% |
Return on Capital Employed (ROCE) | 7.71% | 7.86% | 11.77% | 9.22% | 10.07% | 5.41% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Mar '26 Mar 28, 2026 | Mar '25 Mar 29, 2025 | Mar '24 Mar 30, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 2, 2022 |
Earnings Yield | 2.72% | 3.79% | 5.24% | 2.68% | 2.71% | 1.32% |
FCF Yield | 7.27% | 10.65% | 4.68% | 3.31% | 1.96% | 2.32% |
Buyback Yield / Dilution | 6.65% | 6.65% | 1.30% | 0.04% | -0.13% | -0.12% |
Total Shareholder Return | 6.65% | 6.65% | 1.30% | 0.04% | -0.13% | -0.12% |